With the help of cerebral organoids, IMBA scientists were able to ascertain that Tuberous Sclerosis, a rare neurodevelopmental genetic disorder, arises developmentally rather than only genetically. With these patient-derived laboratory models of the…

The 2021 VBC PhD Symposium brought three out of five awards to IMBA! The theses of Pablo Hofbauer and Michael Mitter, two former PhD candidates at IMBA, were recognized as groundbreaking by the symposium’s scientific panel. Following-up on the…

The 2021 VBC PhD Symposium brought three out of five awards to IMBA! These include two VBC PhD Awards as well as the new Out of the Box Award. We conducted a Q&A session with our three IMBA awardees to learn about their projects, ideas, and plans.…

How does research in biotechnology actually work? Find out with Martin Moder! Was macht eigentlich... Biotechnologische Forschung? Martin Moder fragt nach!

The development of human blastoids, human embryo models at IMBA, paves the way for improving in vitro fertilization success rate and new non-hormonal, user-friendly contraception. This breakthrough from the Rivron lab is now published in the journal…

Researchers identify two sugar-binding proteins that impede the viral entry of circulating SARS-CoV-2 variants. The team, spearheaded by researchers at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – may have found…

Professor Maria Leptin, a long-term member of the IMBA Scientific Advisory Board, was appointed as the next President of the prestigious European Research Council (ERC).

Red2Onco, an innovative genetic mouse model, allows to detect the very initial steps that lead to cancer development. Red2Onco’s multi-colour labelling system allows to trace intestinal tumour development after the first oncogenic hit at the single…

Researchers at the Vienna BioCenter designed a testing protocol for SARS-CoV-2 that can process tens of thousands of samples in less than 48 hours. The method, called SARSeq, is published in the journal Nature Communications and could be adapted to…

Self-organizing heart organoids developed at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – are also effective injury- and in vitro congenital disease models. These “cardioids” may revolutionize research into…